Europe

View All
January 12, 2024 Off

UK Approval for AGAMREE in Duchenne muscular dystrophy treatment

By Dino Mustafić

Santhera Pharmaceuticals has revealed that AGAMREE (vamorolone) has received approval in the United Kingdom (UK) for treating Duchenne muscular dystrophy (DMD) in patients aged 4 and above, regardless of the...

USA

View All
January 2, 2024 Off

Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

By BusinessWire

• Conference call and webcast to be held tomorrow, January 2, at 8:30am ET (5:30am PT) LA JOLLA, Calif.--(BUSINESS WIRE)--$LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused...

My Pharmaceutical

View All
December 29, 2023 Off

I want to become a Cyborg, do you? Also, hear the words for the last weekend of the 2023

By Dino Mustafić

The society is changing rapidly, millennials are now 40 years old people, and it's OK. The Gen-X folks are already planning retirement days, and the world is left into the hands of - I don't even know what do we...

December 29, 2023 Off

A Journey Through Immunization History

By Dino Mustafić

Because we've seen a lot of antivax narratives, let's just give you a brief history of immunization. A Journey Through...

April 13, 2022 Off

Allergan’s BOTOX Cosmetic Celebrates 20th Birthday

By Author

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating 20th anniversary of FDA's approval of Botox Cosmetic.